Mahmood Majeed, ZS, explains why measurable AI outcomes in pharma supply chain and manufacturing jumped from 29% to 53%, and how GMP limits and GxP validation shape adoption.
News|Articles|January 10, 2017
PTSM: Pharmaceutical Technology Sourcing and Management
- PTSM: Pharmaceutical Technology Sourcing and Management-02-01-2017
- Volume 12
- Issue 2
Analysis of Raw Materials
Author(s)Pharmaceutical Technology Editors
B&W Tek’s director of Market and Customer Development, Katherine A. Bakeev, PhD, discusses analysis of pharmaceutical raw materials and the benefits of using handheld Raman spectrometers.
Advertisement
At the 2016
B&W Tek’s director of Market and Customer Development, Katherine A. Bakeev, PhD, discusses analysis of pharmaceutical raw materials and the benefits of using laser-induced breakdown spectroscopy (LIBS).
Articles in this issue
almost 10 years ago
Analytical Technologies for Bio/Pharmaceutical Developmentalmost 10 years ago
Connecting Contractors to a Pharma QMSalmost 10 years ago
Stars Seem Aligned for Healthy CDMO/CMO Marketalmost 10 years ago
New Drug Approvals Slump in 2016almost 10 years ago
Ensuring Quality in Pharmaceutical Raw Materialsalmost 10 years ago
SGS Expands Extractables and Leachables Testingalmost 10 years ago
Vetter Starts Operations in Its Center for Visual Inspection and Logisticsalmost 10 years ago
WuXi AppTec Acquires HD Biosciencesalmost 10 years ago
EAG Laboratories Adds Capabilities in Dermal Absorption Testingalmost 10 years ago
High Street Capital Acquires AvomeenAdvertisement
Related to this article
The PharmTech team focused on its coverage of AAPS PharmSci 360 this week, conducting interviews with experts on a range of topics including formulation platforms, AI, amorphous solid dispersions, and animal studies.
Subathra Ramamoorthy, Veranova, on when to escalate to structural elucidation and pair orthogonal techniques when characterizing an impurity.
The agreement between CDER and OII with allow for coordinated marketing application assessments and inspections.
Nitin Kumar Swarnakar, PhD, global application lab manager at BASF, talks about spray drying for drying amorphous solid dispersions and Raman spectroscopy’s role as a quantitative analytical tool.
Nitin Kumar Swarnakar, PhD, global application lab manager at BASF in Tarrytown, spoke with PharmTech at AAPS PharmSci 360 about formulation and characterization challenges for amorphous solid dispersions.
FDA draft guidance on individualized genome editing lets BLAs add patient-specific variants without new trials, shifting evidence to CMC assay data.
Vibha Jawa, PhD, chief scientific officer at EpiVax, explains why the need for animal studies varies by modality and what it takes for organ-on-chip and other human-relevant models to replace these studies in IND-enabling toxicology work.
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
FDA’s New Inspection Playbook Counts Remote Assessments and MRA Reports Toward Facility Evaluations
2
AI Formulation: Regulators Want Data
3
Late-Phase Impurities Need Reference Standards: AAPS PharmSci 360 2026
4
USP 1074 Revises Excipient Safety: AAPS PharmSci 360 2026
5